73590-93-9Relevant articles and documents
Synthesis and characterization of one impurity in esomeprazole, an antiulcerative drug
Liu, Zhen-Tao,Meng, Xia,Fang, Shi-Min,Wang, Li-Zhen,Wang, Zhen-Zheng,Yang, Geng,Duan, Hong-Dong,Hao, Ai-You
, p. 867 - 877 (2019/09/06)
During drug synthesis, control of impurities is very important to get high-qualified drugs. A number of studies have devoted to synthesize the impurities and study the structures to support the method of purification. In this paper, we first synthesize one impurity in esomeprazole, rel-2-[[(3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-6-methoxy-1H-benzimidazole, with readily available raw materials, simple operation procedures and relatively mild reaction. Besides, we characterized its structure by MS, IR, 1H-NMR and HPLC analyses. The purity of target compound is as high as 99.58%, which can be used as the reference substance of the impurities of esomeprazole.
Synthesis and characterization of metabolites and potential impurities of the antiulcerative drug tenatoprazole
Reddy, Ganta Madhusudhan,Prasada Raju,Babu, J. Moses,Praveen,Khunt, Mayur,Mukkanti,Pratap Reddy, Padi
, p. 1725 - 1736 (2008/09/20)
Tenatoprazole (Ulsacare) is a recently developed antiulcerative drug used for the treatment of both erosive and nonerosive gastroesophageal reflux disease. During the bulk synthesis of tenatoprazole, we have observed four impurities (tenatoprazole N-oxide, tenatoprazole sulfone N-oxide, N-methyl tenatoprazole, and desmethoxy tenatoprazole) and two metabolites (tenatoprazole sulfide and tenatoprazole sulfone). The present work describes the synthesis and characterization of these impurities. Copyright Taylor & Francis Group, LLC.